If approved REO will most definately be a $1 Billion / year drug.
$1 Billion in sales = $100. in stock price.
Reo could be for 10 different indications.
$100 x 10 = $1,000 stock price.
REO is cheap to manufacture .
REO has no bad side effects like Chemo.
REO had good P2 trial results
The Natl Cancer Institute is sponsoring 4 of their trials
The Canadian Natl Cancer Institute is sponsoring 4 of their trials.
(Lipator was a $7 Billion drug.)
(DNDN went from $5/ share to $35 upon good trial results.)
ONCY seems like better odds to me than a lottery ticket.
The stocks you should worry about should be the risky ones( just taken out of the DOW ) like Bank of America & Hewlett Packard with old technology.
Its not "really" down 12 cents. Yesterday the price was pretty stable for hours around 2.71 especially at the end. Then there was a single purchase that jumped the price from 2.71 to 2.82. This was an outlier. Why someone was willing to pay 5% more than the going price I don't know. But it doesn't reflect what the whole market thought the price was. So, using the more reflective closing price of 2.71, we are only down 1 cent right now.